Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD)
Publication
, Conference
Suzuki, A; Spencer, HJ; Moylan, CA; Dranoff, JA; Abdelmalek, MF; Guy, CD; Diehl, AM
Published in: HEPATOLOGY
October 1, 2016
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2016
Volume
64
Start / End Page
105A / 105A
Location
Boston, MA
Publisher
WILEY
Conference Name
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Suzuki, A., Spencer, H. J., Moylan, C. A., Dranoff, J. A., Abdelmalek, M. F., Guy, C. D., & Diehl, A. M. (2016). Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD). In HEPATOLOGY (Vol. 64, pp. 105A-105A). Boston, MA: WILEY.
Suzuki, Ayako, Horace J. Spencer, Cynthia A. Moylan, Jonathan A. Dranoff, Manal F. Abdelmalek, Cynthia D. Guy, and Anna Mae Diehl. “Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD).” In HEPATOLOGY, 64:105A-105A. WILEY, 2016.
Suzuki A, Spencer HJ, Moylan CA, Dranoff JA, Abdelmalek MF, Guy CD, et al. Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD). In: HEPATOLOGY. WILEY; 2016. p. 105A-105A.
Suzuki, Ayako, et al. “Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD).” HEPATOLOGY, vol. 64, WILEY, 2016, pp. 105A-105A.
Suzuki A, Spencer HJ, Moylan CA, Dranoff JA, Abdelmalek MF, Guy CD, Diehl AM. Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD). HEPATOLOGY. WILEY; 2016. p. 105A-105A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2016
Volume
64
Start / End Page
105A / 105A
Location
Boston, MA
Publisher
WILEY
Conference Name
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics